Target intelligence / Profile preview

Dengue Virus Serotype 1 (DENV-1)

Target
DENV-1
Molecular classification
Virus, Flavivirus
01

Overview

Dengue virus serotype 1 (DENV-1) is one of four antigenically distinct serotypes of the dengue virus, a mosquito-borne pathogen belonging to the genus *Flavivirus*. DENV-1 is an enveloped, positive-sense, single-stranded RNA virus. It is transmitted primarily by *Aedes* mosquitoes and can cause a spectrum of disease in humans ranging from mild febrile illness to severe hemorrhagic fever and shock syndrome. Entry into host cells involves initial binding to specific receptors like the 37/67-kDa high-affinity laminin receptor and heparan sulfate on the cell surface. DENV‑1 can be detected using molecular assays such as real-time RT-PCR. Infection with DENV-1 can result in asymptomatic infection or classic dengue fever. Distinct clinical features associated with DENV‑1 include a higher likelihood of red eyes compared to other serotypes. Sequential infections by different dengue virus serotypes increase the risk for more severe disease due to immune enhancement mechanisms.

Other names
DENV1Dengue virus 1Dengue serotype 1
02

Mechanism of action

Viral infection and replication within host cells, leading to inflammation and potential vascular leakage.

03

Biological functions

Viral replicationHost cell entryImmune evasionPathogenesis
04

Disease associations

Dengue feverDengue hemorrhagic feverDengue shock syndromeInfection
05

Safety considerations

Antibody-dependent enhancement (ADE) with subsequent dengue infectionsRisk of severe dengue manifestations (DHF/DSS)Lack of cross-protective immunity to other serotypes
06

Biomarkers

DENV-1 RNA levels in serum or plasmaNS1 antigenIgM/IgG antibodies

Beyond the preview

Go deeper on Dengue Virus Serotype 1 (DENV-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue Virus Serotype 1 (DENV-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call